UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): January 19, 2015

                                 AMERICANN, INC.
                    -----------------------------------------
             (Exact name of registrant as specified in its charter)

         Delaware                     000-54231                27-4336843
  ------------------------       ------------------        -----------------
(State or other jurisdiction    (Commission File No.)     (IRS Employer
  of incorporation)                                        Identification No.)

                          3200 Brighton Blvd. Unit 114
                                Denver, CO 80216
                -----------------------------------------------
          (Address of principal executive offices, including Zip Code)

     Registrant's telephone number, including area code: (303) 862-9000


         (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
     CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

Item 8.01   Other Events

     In September 2014 the Company  entered into agreements with two groups that
applied for cannabis cultivation  licenses as a part of Illinois'  Compassionate
Use of Medical Cannabis Pilot Program Act (CUMCPP).

     Under the terms of the agreements,  in addition to consulting,  the Company
would  provide  capital  for  the  acquisition  of  land,  working  capital  and
construction of new cannabis cultivation facilities.

     The Company's  obligations  with respect to the  applicants  are contingent
upon the State of Illinois  granting  licenses to these  applicants as a part of
the CUMCPP.

     On January 12, 2015 the outgoing Governor of Illinois'  administration  did
not make a decision  on the  awarding  of  licenses  under  CUMCPP.  The lack of
decision  under  Governor  Quinn's   administration  may  cause  delays  in  the
announcement of dispensary and cultivation licenses.

     The new administration,  which took office on January 12, 2015, will now be
responsible for awarding licenses under the CUMCPP. It is uncertain if, or when,
such licenses will be granted under the new administration.

---------------

     On December 31, 2014 the Company and Canna LLC mutually agreed to terminate
Canna LLC's consulting relationship with the Company.

                                       2
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Date:  January 19, 2015
                                 AMERICANN, INC.


                                 By: /s/ Timothy Keogh
                                     --------------------------------------
                                     Timothy Keogh, Chief Executive Officer
[{"type": "8-K", "sequence": "1", "filename": "form8kitem801jan-15.txt", "description": "FORM 8-K ITEM 8.01", "secsgml_size_bytes": 3761}]
{"company-data": {"conformed-name": "Americann, Inc.", "cik": "0001508348", "assigned-sic": "6770", "irs-number": "274336843", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54231", "film-number": "15535396"}, "business-address": {"street1": "1550 LARIMER", "street2": "SUITE 264", "city": "DENVER", "state": "CO", "zip": "80202", "phone": "(303) 839-0061"}, "mail-address": {"street1": "1550 LARIMER", "street2": "SUITE 264", "city": "DENVER", "state": "CO", "zip": "80202"}, "former-company": {"former-conformed-name": "Nevada Health Scan, Inc.", "date-changed": "20101220"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): January 19, 2015

                                 AMERICANN, INC.
                    -----------------------------------------
             (Exact name of registrant as specified in its charter)

         Delaware                     000-54231                27-4336843
  ------------------------       ------------------        -----------------
(State or other jurisdiction    (Commission File No.)     (IRS Employer
  of incorporation)                                        Identification No.)

                          3200 Brighton Blvd. Unit 114
                                Denver, CO 80216
                -----------------------------------------------
          (Address of principal executive offices, including Zip Code)

     Registrant's telephone number, including area code: (303) 862-9000

         (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
     CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))
Item 8.01   Other Events

     In September 2014 the Company  entered into agreements with two groups that
applied for cannabis cultivation  licenses as a part of Illinois'  Compassionate
Use of Medical Cannabis Pilot Program Act (CUMCPP).

     Under the terms of the agreements,  in addition to consulting,  the Company
would  provide  capital  for  the  acquisition  of  land,  working  capital  and
construction of new cannabis cultivation facilities.

     The Company's  obligations  with respect to the  applicants  are contingent
upon the State of Illinois  granting  licenses to these  applicants as a part of
the CUMCPP.

     On January 12, 2015 the outgoing Governor of Illinois'  administration  did
not make a decision  on the  awarding  of  licenses  under  CUMCPP.  The lack of
decision  under  Governor  Quinn's   administration  may  cause  delays  in  the
announcement of dispensary and cultivation licenses.

     The new administration,  which took office on January 12, 2015, will now be
responsible for awarding licenses under the CUMCPP. It is uncertain if, or when,
such licenses will be granted under the new administration.

---------------

     On December 31, 2014 the Company and Canna LLC mutually agreed to terminate
Canna LLC's consulting relationship with the Company.

                                       2
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date:  January 19, 2015
                                 AMERICANN, INC.

                                 By: /s/ Timothy Keogh
                                     --------------------------------------
                                     Timothy Keogh, Chief Executive Officer